US · Healthcare

Foghorn Therapeutics Inc (FHTX)

Biotechnology

Foghorn Therapeutics Inc (FHTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FHTX

P/E ratio

18.00

Foghorn Therapeutics Inc (FHTX) — FAQ

What is FHTX's P/E ratio?

The price-to-earnings (P/E) ratio for Foghorn Therapeutics Inc (FHTX) is 18.00 (data as of 2026-03-24).

Does Foghorn Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Foghorn Therapeutics Inc (FHTX). Check the MyAverix Finance app for the latest dividend data.

What sector is Foghorn Therapeutics Inc in?

Foghorn Therapeutics Inc (FHTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is FHTX listed on?

FHTX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)